The lesson
When the buyer is scientific, tell the case study as a short study report with data sources, method, outcomes and next steps, and let one chart carry the result.
A "Case Study" label and the title sit beside an image of a networked human figure. "Introduction & Background" names the AAD, Boehringer Ingelheim and OM1, and "Data Sources" describes two cohorts, one from DataDerm (54 million patient encounters, 14 million unique patients) and one from the OM1 Real-World Data Cloud (approximately 340 million individuals), with a diagram linking the two. "OM1 Patient Finder: How it Works" explains digital phenotype 'fingerprints' and walks through calibration and ranking in illustrated steps. "Outcomes" gives 1,883 and 7,558 patients, an AUROC of 0.80 and "approximately 40 times more likely" for the flagged group, shown as a Full Population versus Top 0.1% pictogram, and "Looking Ahead" closes on validation and use in clinic, followed by partner logos and related case studies.
Don't copy OM1's GPP subject, the AUROC and prevalence framing, or the three-party partnership setup. Keep the research-paper section order, the data sources stated before the method, a step diagram for the method, one comparison chart under the outcomes, and a closing section that is honest about what still needs validating.
Tell us what you want to make. We’ll talk through how to put these ideas to work for your brand.